🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in Post-Stroke Rehabilitation

RecruitingNAAges 40 Years - 75 YearsAllUniversity of Faisalabad
NCT07523503 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized clinical trial will examine upper limb rehabilitation in individuals recovering from stroke. The study will compare unilateral and bilateral task-oriented training approaches to determine their relative effectiveness. Thirty-two medically stable participants with active shoulder movement and adequate cognition will be enrolled into two groups. Both groups will receive structured training for four weeks. Outcomes related to motor function and dexterity will be measured using standardized assessment tools. The aim is to identify the more effective strategy for improving upper extremity function after stroke.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * • Age between 40 and 75 years * Clinically diagnosed stroke (no more than three lifetime episodes) * Stroke duration between 6 to 24 months * Ability to perform antigravity shoulder movement with the paretic limb * Abbreviated Mental Test score ≥ 7 * Medically stable and capable of giving consent Exclusion Criteria: * • Uncontrolled systemic conditions (e.g. Unstable cardiac conditions) * Major orthopedic issues affecting the involved upper limb * Hearing deficits * Allergy to electrodes * Receptive aphasia or severe language impairment * Severe joint contracture limiting required upper limb movements
💊

What it tests

  • Unilateral task oriented training (UTOT) with baseline EMS
  • Bilateral task oriented training (BTOT) with baseline EMS
📍

Where

1 site
Hospitals
Kot Addu, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy